Trials / Completed
CompletedNCT03210740
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- AmDerma · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions
Detailed description
A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AM001 Cream, 7.5% | Active Cream |
| DRUG | Vehicle Cream | Placeo |
Timeline
- Start date
- 2017-06-06
- Primary completion
- 2018-02-13
- Completion
- 2018-04-24
- First posted
- 2017-07-07
- Last updated
- 2019-04-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03210740. Inclusion in this directory is not an endorsement.